Oloker Therapeutics
PrivateLast Round
Seed
Apr 2, 2021
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Oloker Therapeutics is a biotechnology company that develops cellular therapies for the treatment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oloker Therapeutics Comparables
Compare Oloker Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Secretome Therapeutics | 69% | |
| CytoHub Inc. | 45% | |
| Pluri | 42% |
Oloker Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 2, 2021 |
Oloker Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Siryo SpA | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 1208% MoM, reaching 2.3K.
Oloker Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oloker Therapeutics's valuation, stock price, and market status.
Is Oloker Therapeutics a public or private company?
Oloker Therapeutics is a private company.
What is the current stock price of Oloker Therapeutics?
Oloker Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Oloker Therapeutics worth (valuation)?
Valuation information for Oloker Therapeutics is not publicly available.
Can I buy Oloker Therapeutics stock?
Oloker Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oloker Therapeutics's last funding round?
Oloker Therapeutics's most recent funding round was Seed on April 2, 2021.
Who are the main investors in Oloker Therapeutics?
Key investors in Oloker Therapeutics include Siryo SpA.
Will Oloker Therapeutics IPO soon?
No public IPO plans have been announced for Oloker Therapeutics.
How can I track Oloker Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oloker Therapeutics's secondary market activity and sign up for updates.